Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization

References

• Ainbinder D, Touitou E. Testosterone ethosomes for enhanced transdermal delivery. Drug Delivery 2005; 12: 297–303
   PubMed Web of Science ®Google Scholar
• Alberti I, Grenier A, Kraus H, Carrara DN. Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery. Expert Opinion on Drug Delivery 2005; 2: 935–950
   PubMed Web of Science ®Google Scholar
• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. European Journal of Pharmaceutical Science 2001; 14: 101–114
   PubMed Web of Science ®Google Scholar
• Borgia SL, Regehly M, Sivaramakrishanan R, Mehnert W, Korting HC, Danker K, Röder B, Kramer KD, Schäfer-Korting M. Lipid nanoparticles for skin penetration enhancement–correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. Journal of Controlled Release 2005; 110: 151–163
   PubMed Web of Science ®Google Scholar
• Brand RM, Dusensing G, Hamel FG. Iontophoretic delivery of an insulin-mimetic peroxovanadium compound. International Journal of Pharmaceutics 1997; 146: 115–122
   Web of Science ®Google Scholar
• Bunjes H, Westesen K, Koch MH. Complex fats as matrix constitutions in lipid nanoparticles. Proceedings of the 1st World Meeting of APGI/APV. May. BudapestAustralia 1995; 497–498, 9/11
   Google Scholar
• Bunjes H, Westesen K, Koch MH. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. International Journal of Pharmaceutics 1996; 129: 159–173
   Web of Science ®Google Scholar
• Cantrill JA, Dewis P, Large DM, Newman M, Anderson DC. Which testosterone replacement therapy?. Clinical Endocrinology 1984; 21: 97–107
   PubMed Web of Science ®Google Scholar
• Cavalli R, Caputo O, Carlotti ME, Trotta M, Scarnecchia C, Gasco MR. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. International Journal of Pharmaceutics 1997; 148: 47–54
   Web of Science ®Google Scholar
• Cortesi R, Eaposito E, Luca G, Nastruzzi C. Production of lipospheres as carriers for bioactive compounds. Biomaterials 2002; 23: 2283–2294
   PubMed Web of Science ®Google Scholar
• Eldem T, Speiser P, Altorfer H. Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy. Pharmaceutical Research 1991; 82: 178–184
   Web of Science ®Google Scholar
• Freitas C, Müller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. European Journal of Pharmaceutics and Biopharmaceutics 1999; 47: 125–132
   PubMed Web of Science ®Google Scholar
• Gavini E, Sanna V, Sharma R, Juliano C, Usai M, Marchetti M, Karlsen J, Giunchedi P. Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: Preliminary studies. Pharmaceutical Development and Technology 2005; 10: 479–487
   PubMed Web of Science ®Google Scholar
• Gooren LJG, Bunck MCM. Transdermal testosterone delivery: Testosterone patch and gel. World Journal of Urology 2003; 21: 316–319
   PubMed Web of Science ®Google Scholar
• Hamdani J, Moës AJ, Amighi K. Physical and thermal characterization of Precirol® and Compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pellets. International Journal of Pharmaceutics 2003; 260: 47–57
   PubMed Web of Science ®Google Scholar
• Heiati H, Tawashi R, Philips NC. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage, and lyophilisation. Jounal of Microencapsulation 1998; 15: 173–184
   PubMed Web of Science ®Google Scholar
• Ho HO, Huang FC, Sokoloski TD, Sheu MT. The influence of cosolvents on the in-vitro percutaneous penetration of diclofenac sodium from a gel system. Journal of Pharmacy and Pharmcology 1994; 46: 636–642
   PubMed Web of Science ®Google Scholar
• Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLN). Biomaterials 2003; 24: 1781–1785
   PubMed Web of Science ®Google Scholar
• Jaspart S, Piel G, Delattre L, Evrard B. Solid lipid microparticles: Formulation, preparation, characterisation, drug release, and applications. Expert Opinion on Drug Delivery 2005; 2: 75–87
   PubMedGoogle Scholar
• Jenning V, Schafer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. Journal of Controlled Release 2000; 66: 115–126
   PubMed Web of Science ®Google Scholar
• Kim M, Zhao H, Lee C, Kim D. Formulation of a reservoir-type testosterone transdermal delivery system. International Journal of Pharmaceutics 2001; 219: 51–59
   PubMed Web of Science ®Google Scholar
• Leichtnam ML, Rolland H, Wuthrich P, Guy RH. Formulation and evaluation of a testosterone transdermal spray. Journal of Pharmaceutical Sciences 2006; 95: 1693–1702
   PubMed Web of Science ®Google Scholar
• Lippacher A, Müller RH, Mäder K. Investigation on the viscoelastic properties of lipid based colloidal drug carriers. International Journal of Pharmaceutics 2000; 196: 227–230
   PubMed Web of Science ®Google Scholar
• Lippacher A, Müller RH, Mader K. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. International Journal of Pharmaceutics 2001; 214: 9–12
   PubMed Web of Science ®Google Scholar
• Lippacher A, Müller RH, Mäder K. Semisolid SLN dispersion for topical application: Influence of formulation and production parameters on viscoelastic properties. European Journal of Pharmaceutics and Biopharmaceutics 2002; 53: 155–160
   PubMed Web of Science ®Google Scholar
• Lippacher A, Müller RH, Mäder K. Liquid and semisolid SLN dispersions for topical application: Rheological characterization. European Journal of Pharmaceutics and Biopharmaceutics 2004; 58: 561–567
   PubMed Web of Science ®Google Scholar
• Mazer NA. New clinical applications of transdermal testosterone delivery in men and women. Journal of Controlled Release 2000; 65: 303–315
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles production, characterization, and applications. Advanced Drug Delivery Review 2001; 47: 165–196
   PubMed Web of Science ®Google Scholar
• Mehnert W, zur Mühlen A, Dingler A, Weyhers H, Müller RH. Solid lipid nanoparticles (SLN)—ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. Wirkstoff-Inkorporarion, Freisetzung und Sterilizierbarkeit, Pharmacetical Industries 1997; 59: 511–514
   Google Scholar
• Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. European Journal of Pharmaceutics and Biopharmaceutics 2003; 56: 189–196
   PubMed Web of Science ®Google Scholar
• Mills PC, Magnusson BM, Cross SE. The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin. The Veterinary Journal 2006; 171: 276–280
   PubMed Web of Science ®Google Scholar
• Mobley WC, Schreier H. Phase transition temperature reduction and glass transformation in dehydroprotected lyophilized liposomes. Journal of Controlled Release 1994; 31: 73–87
   Web of Science ®Google Scholar
• Morgan TM, Reed BL, Finnin BC. Enhanced skin permeation of sex hormones with novel topical spray vehicles. Journal of Pharmaceutical Sciences 1998; 87: 1213–1218
   PubMed Web of Science ®Google Scholar
• Müller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Advanced. Drug Delivery Review 2001; 47: 3–19
   PubMed Web of Science ®Google Scholar
• Rao R, Diwan P, Prakash V. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Development and Industrial Pharmacy 1998; 24: 327–336
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization. Journal of Microencapsulation 1999; 16: 205–213
   PubMed Web of Science ®Google Scholar
• Siekmann B, Westesen K. Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. I. Preparation and particle size determination. Pharmaceutical and Pharmacological Letter 1994a; 3: 194–197
   Google Scholar
• Siekmann B, Westesen K. Melt-homogenized solid lipid nanoparticles stabilized by the non ionic surfactant tyloxapol. II Physicochemical characterization and lyophilisation. Pharmaceutical and Pharmacological Letter 1994b; 3: 225–228
   Google Scholar
• Somboonporn W. Testosterone therapy for postmenopausal women: Efficacy and safety. Seminars in Reproductive Medicine 2006; 24: 115–124
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. International Journal of Pharmaceutics 2004a; 278: 71–77
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. European Journal of Pharmaceutics and Biopharmaceutics 2004b; 58: 83–90
   PubMed Web of Science ®Google Scholar
• Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. Journal of. Controlled Release 2004; 95: 627–638
   PubMed Web of Science ®Google Scholar
• Westesen K, Bunjes H, Koch MHJ. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. Journal of Controlled Release 1997; 48: 223–236
   Web of Science ®Google Scholar
• Westesen K, Siekmann B, Koch MHL. Investigations on the physical state of lipid nanoparticles by synchrotron X-ray diffraction. International Journal of Pharmaceutics 1993; 93: 189–199
   Web of Science ®Google Scholar
• Zimmermann E, Müller RH. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media. European Journal of Pharmaceutics and Biopharmaceutics 2001; 52: 203–210
   PubMed Web of Science ®Google Scholar
• Zimmermann E, Müller RH, Mäder K. Influence of different parameters on reconstitution of lyophilized SLN. International Journal of Pharmaceutics 2000; 196: 211–213
   PubMed Web of Science ®Google Scholar